Reference
Foerster R, et al. Reversible posterior leucoencephalopathy syndrome (RPLS) associated with pazopanib. Journal of Clinical Oncology 31 (Suppl. 1): No. 151, 20 May 2013 [Abstact]. - Germany
Rights and permissions
About this article
Cite this article
Pazopanib. Reactions Weekly 1461, 32 (2013). https://doi.org/10.1007/s40278-013-4642-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-4642-0